78 related articles for article (PubMed ID: 9690405)
21. Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: first three case reports.
Kawamura T; Ito Y; Ito E; Takeda M; Mikami T; Taguchi T; Mochizuki-Oda N; Sasai M; Shimamoto T; Nitta Y; Yoshioka D; Kawamura M; Kawamura A; Misumi Y; Sakata Y; Sawa Y; Miyagawa S
Front Cardiovasc Med; 2023; 10():1182209. PubMed ID: 37781295
[TBL] [Abstract][Full Text] [Related]
22. Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 Study.
Starling RC; Stehlik J; Baran DA; Armstrong B; Stone JR; Ikle D; Morrison Y; Bridges ND; Putheti P; Strom TB; Bhasin M; Guleria I; Chandraker A; Sayegh M; Daly KP; Briscoe DM; Heeger PS;
Am J Transplant; 2016 Jan; 16(1):121-36. PubMed ID: 26260101
[TBL] [Abstract][Full Text] [Related]
23. Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss.
O'Leary JG; Kaneku H; Demetris AJ; Marr JD; Shiller SM; Susskind BM; Tillery GW; Terasaki PI; Klintmalm GB
Liver Transpl; 2014 Feb; 20(2):218-27. PubMed ID: 24382837
[TBL] [Abstract][Full Text] [Related]
24. Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys.
Kelishadi SS; Azimzadeh AM; Zhang T; Stoddard T; Welty E; Avon C; Higuchi M; Laaris A; Cheng XF; McMahon C; Pierson RN
J Clin Invest; 2010 Apr; 120(4):1275-84. PubMed ID: 20335656
[TBL] [Abstract][Full Text] [Related]
25. HLA antibody analysis: sensitivity, specificity, and clinical significance in solid organ transplantation.
Zeevi A; Girnita A; Duquesnoy R
Immunol Res; 2006; 36(1-3):255-64. PubMed ID: 17337786
[TBL] [Abstract][Full Text] [Related]
26. Activation-induced T cell death, and aberrant T cell activation via TNFR1 and CD95-CD95 ligand pathway in stable cardiac transplant recipients.
Ankersmit HJ; Moser B; Zuckermann A; Roth G; Taghavi S; Brunner M; Wolner E; Boltz-Nitulescu G
Clin Exp Immunol; 2002 Apr; 128(1):175-80. PubMed ID: 11982606
[TBL] [Abstract][Full Text] [Related]
27. Cardiac transplantation.
Deng MC
Heart; 2002 Feb; 87(2):177-84. PubMed ID: 11796563
[No Abstract] [Full Text] [Related]
28. [Endomyocardial biopsy in the heart transplant patient: the state of the art].
Arbustini E; Grasso M; Diegoli M; Gavazzi A; Campana C; Martinelli L; Goggi C; Pucci A; Grossi P; Ippoliti G
G Ital Cardiol; 1991 Oct; 21(10):1107-23. PubMed ID: 1804749
[TBL] [Abstract][Full Text] [Related]
29. The challenge of endomyocardial biopsy interpretation in assessing cardiac allograft rejection.
Winters GL
Curr Opin Cardiol; 1997 Mar; 12(2):146-52. PubMed ID: 9192483
[TBL] [Abstract][Full Text] [Related]
30. Clinical relevance of in vitro propagation of activated lymphocytes from endomyocardial biopsy samples of pediatric heart transplant recipients.
Webber SA; Bentlejewski C; Park A; Fricker FJ; Griffith C; Boyle GJ; Miller SA; Pham S; Murali S; Griffith BP; Duquesnoy R; Zeevi A
Pediatr Transplant; 1998 Aug; 2(3):200-5. PubMed ID: 10084743
[TBL] [Abstract][Full Text] [Related]
31. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
[TBL] [Abstract][Full Text] [Related]
32. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
[TBL] [Abstract][Full Text] [Related]
33. The relationship of nodular endocardial infiltrates (Quilty lesions) to survival, patient age, anti-HLA antibodies, and coronary artery disease following heart transplantation.
Chu KE; Ho EK; de la Torre L; Vasilescu ER; Marboe CC
Cardiovasc Pathol; 2005; 14(4):219-24. PubMed ID: 16009321
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
[TBL] [Abstract][Full Text] [Related]
35. An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients.
Itescu S; Tung TC; Burke EM; Weinberg AD; Mancini D; Michler RE; Suciu-Foca NM; Rose EA
Lancet; 1998 Jul; 352(9124):263-70. PubMed ID: 9690405
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
